Field | Row 1 |
---|---|
adsh | 0000950170-25-061469 |
cik | 1828161 |
name | FTC SOLAR, INC. |
sic | 3674 |
countryba | US |
stprba | TX |
cityba | AUSTIN |
zipba | 78759 |
bas1 | 9020 N CAPITAL OF TEXAS HWY, SUITE I-260 |
bas2 | |
baph | (907) 312-0717 |
countryma | US |
stprma | TX |
cityma | AUSTIN |
zipma | 78759 |
mas1 | 9020 N CAPITAL OF TEXAS HWY, SUITE I-260 |
mas2 | |
countryinc | US |
stprinc | DE |
ein | 814816270 |
former | |
changed | |
afs | 4-NON |
wksi | 0 |
fye | 1231 |
form | 10-Q |
period | 20250331 |
fy | 2025 |
fp | Q1 |
filed | 20250501 |
accepted | 2025-05-01 09:16:00.0 |
prevrpt | 0 |
detail | 1 |
instance | ftci-20250331_htm.xml |
nciks | 1 |
aciks |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
countryba | The ISO 3166-1 country of the registrant's business address. |
stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
cityba | The city of the registrant's business address. |
zipba | The zip code of the registrant’s business address. |
bas1 | The first line of the street of the registrant’s business address. |
bas2 | The second line of the street of the registrant’s business address. |
baph | The phone number of the registrant’s business address. |
countryma | The ISO 3166-1 country of the registrant's mailing address. |
stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
cityma | The city of the registrant's mailing address. |
zipma | The zip code of the registrant’s mailing address. |
mas1 | The first line of the street of the registrant’s mailing address. |
mas2 | The second line of the street of the registrant’s mailing address. |
countryinc | The ISO 3166-1 country of incorporation for the registrant. |
stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
former | Most recent former name of the registrant, if any. |
changed | Date of change from the former name, if any. |
afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
fye | Fiscal Year End Date, rounded to nearest month-end. |
form | The submission type of the registrant’s filing. |
period | Balance Sheet Date, rounded to nearest month-end. |
fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
filed | The date of the registrant’s filing with the Commission. |
accepted | The acceptance date and time of the registrant’s filing with the Commission. |
prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
---|---|---|---|---|---|---|---|---|---|
0000950170-25-061469 | 20241231 | Accounts And Financing Receivable Allowance For Credit Loss | 1717000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Accounts Payable Current | 12995000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Accrued Liabilities Current | 20134000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Additional Paid In Capital | 367601000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Cash Paid During The Period For Third Party Interest | 140000.0000 | USD | 1 | 0000950170-25-061469 | |||
0000950170-25-061469 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Common Stock Value | 1000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Cost Of Goods And Services Sold | 2328000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Service; | ||
0000950170-25-061469 | 20250331 | Cost Of Goods And Services Sold | 24250000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Cost Of Goods And Services Sold | 4139000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Service; | ||
0000950170-25-061469 | 20240331 | Depreciation And Amortization | 404000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Increase Decrease In Accounts Receivable | 1770000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Increase Decrease In Other Operating Assets | 216000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Increase Decrease In Other Operating Capital Net | 287000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Inventory Net | 10144000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Liabilities Current | 49073000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Long Term Debt | 9466000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Net Cash Provided By Used In Operating Activities | -8483000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Payments To Acquire Property Plant And Equipment | 432000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Prepaid Expense And Other Assets Current | 15028000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Proceeds From Sale Of Equity Method Investments | 3204000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Proceeds From Sale Of Property Plant And Equipment | 3000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Product Warranty Expense | 838000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Property Plant And Equipment Net | 2217000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Property Plant And Equipment Net | 2217000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Property Plant And Equipment Net | 1951000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Purchase Of Property And Equipment Included In Account Payable | 4000.0000 | USD | 1 | 0000950170-25-061469 | |||
0000950170-25-061469 | 20231231 | Stockholders Equity | -299135000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-061469 | 20240331 | Stockholders Equity | -307906000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-061469 | 20241231 | Stockholders Equity | 19036000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Stockholders Equity | -542000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000950170-25-061469 | 20241231 | Stockholders Equity | 367318000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-061469 | 20250331 | Stockholders Equity | -514000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000950170-25-061469 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Gross | 209486.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-061469 | 20241231 | Warrant Liability | 9520000.0000 | USD | 0 | 0000950170-25-061469 | |||
0000950170-25-061469 | 20250331 | Warrant Liability | 4916000.0000 | USD | 0 | 0000950170-25-061469 | |||
0000950170-25-061469 | 20250331 | Gross Profit | -3447000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Accrued Liabilities Current | 23245000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | -514000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Cash And Cash Equivalents At Carrying Value | 5909000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Common Stock Shares Issued | 12853823.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Deferred Income Tax Expense Benefit | 426000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Depreciation And Amortization | 302000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Earnings Per Share Basic | -0.3000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Gain Loss On Sale Of Property Plant Equipment | 0.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | General And Administrative Expense | 5053000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -8782000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Income Taxes Paid | 58000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Income Tax Expense Benefit | 254000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Increase Decrease In Other Accounts Payable And Accrued Liabilities | -6200000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Increase Decrease In Other Accounts Payable And Accrued Liabilities | 2539000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Interest Expense | 317000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Interest Expense | 711000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Interest Income Operating | 181000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Inventory Net | 6828000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Liabilities | 70892000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Net Cash Provided By Used In Investing Activities | 3124000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Operating Lease Liability Noncurrent | 344000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 5909000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250228 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Longterm Debt Type= Term Sheet; Subsidiary Sale Of Stock= Private Placement; | ||
0000950170-25-061469 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Common Stock Value | 1000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Cost Of Goods And Services Sold | 20111000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Product; | ||
0000950170-25-061469 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -59000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | General And Administrative Expense | 6567000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Income Taxes Paid | 7000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Increase Decrease In Other Noncurrent Liabilities | -415000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Liabilities And Stockholders Equity | 89928000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Net Cash Provided By Used In Investing Activities | 2618000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal | 670000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Operating Lease Right Of Use Asset | 1149000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 28000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Other Liabilities Current | 10313000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Paid In Kind Non Cash Interest Added To Senior Notes Principal | 0.0000 | USD | 1 | 0000950170-25-061469 | |||
0000950170-25-061469 | 20240331 | Proceeds From Sale Of Equity Method Investments | 4085000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Proceeds From Stock Options Exercised | 0.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Shares Outstanding | 1076257.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock1; | ||
0000950170-25-061469 | 20231231 | Stockholders Equity | 62471000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Stockholders Equity | 55158000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock1; | ||
0000950170-25-061469 | 20250331 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-061469 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 5000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-061469 | 20241231 | Taxes Payable Current | 325000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Treasury Stock Common Shares | 1076257.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Warrants Recoverable From Manufacturer | -80000.0000 | USD | 1 | 0000950170-25-061469 | |||
0000950170-25-061469 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 12556938.0000 | shares | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Other Comprehensive Income Loss Net Of Tax | 28000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Other Noncash Income Expense | -309000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Other Nonoperating Income Expense | 4000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Payments To Acquire Property Plant And Equipment | 83000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Retained Earnings Accumulated Deficit | -351560000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Share Based Compensation | 280000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Shares Outstanding | 12853823.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-061469 | 20240331 | Stockholders Equity | 363537000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-061469 | 20240331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
0000950170-25-061469 | 20250331 | Stockholders Equity | 15528000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Accounts And Financing Receivable Allowance For Credit Loss | 1625000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Accounts Payable Current | 1200000.0000 | USD | 0 | us-gaap/2024 | Schedule Of Equity Method Investment Equity Method Investee Name= Alpha Steel; | ||
0000950170-25-061469 | 20250331 | Accounts Receivable Net Current | 44238000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | -542000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Additional Paid In Capital | 367318000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Assets | 84061000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -9298000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Cost Of Goods And Services Sold | 14695000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Earnings Per Share Diluted | -0.7000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Equity Method Investment Realized Gain Loss On Disposal | 3204000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Goodwill | 7213000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -918000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal | -92000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Operating Lease Liability Noncurrent | 411000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Operating Lease Right Of Use Asset | 959000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Other Comprehensive Income Loss Net Of Tax | 28000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000950170-25-061469 | 20241231 | Other Liabilities Noncurrent | 2422000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Payments To Acquire Other Investments | 1035000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1639000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1639000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-061469 | 20250331 | Amortization Of Financing Costs | 210000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Assets | 89928000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Cash And Cash Equivalents At Carrying Value | 14041000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 25235000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 15937000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Interest Income Operating | 6000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Liabilities | 68533000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -5338000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Earnings Per Share Basic | -0.7000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Equity Method Investments | 842000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Fair Value Adjustment Of Warrants | 0.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Increase Decrease In Deferred Revenue | -3069000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Increase Decrease In Other Operating Assets | 226000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Net Cash Provided By Used In Financing Activities | 3000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Net Cash Provided By Used In Operating Activities | -11857000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Net Income Loss | -8771000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-061469 | 20250331 | Net Income Loss | -3819000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Operating Expenses | 10394000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Operating Expenses | 7113000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Other Comprehensive Income Loss Net Of Tax | -181000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Other Liabilities Current | 10373000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Other Noncash Income Expense | -327000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Other Nonoperating Income Expense | 36000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Provision For Inventory Obsolescence | 0.0000 | USD | 1 | 0000950170-25-061469 | |||
0000950170-25-061469 | 20240331 | Purchase Of Property And Equipment Included In Account Payable | 175000.0000 | USD | 1 | 0000950170-25-061469 | |||
0000950170-25-061469 | 20250331 | Research And Development Expense | 924000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 12587000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Selling And Marketing Expense | 1136000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20231231 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
0000950170-25-061469 | 20240331 | Shares Outstanding | 1076257.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock1; | ||
0000950170-25-061469 | 20231231 | Stockholders Equity | -293000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000950170-25-061469 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock1; | ||
0000950170-25-061469 | 20241231 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-061469 | 20250331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock1; | ||
0000950170-25-061469 | 20250331 | Taxes Payable Current | 407000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 12556938.0000 | shares | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Proceeds From Sale Of Property Plant And Equipment | 0.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 1682000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Service; | ||
0000950170-25-061469 | 20240331 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
0000950170-25-061469 | 20231231 | Stockholders Equity | 361898000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-061469 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
0000950170-25-061469 | 20241231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
0000950170-25-061469 | 20241231 | Stockholders Equity | -347741000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-061469 | 20250331 | Stockholders Equity | 367601000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-061469 | 20241231 | Treasury Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Warrants Recoverable From Manufacturer | -98000.0000 | USD | 1 | 0000950170-25-061469 | |||
0000950170-25-061469 | 20231231 | Accounts And Financing Receivable Allowance For Credit Loss | 8557000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Accounts And Financing Receivable Allowance For Credit Loss | 9227000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Accounts Payable Current | 500000.0000 | USD | 0 | us-gaap/2024 | Schedule Of Equity Method Investment Equity Method Investee Name= Alpha Steel; | ||
0000950170-25-061469 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 280000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 280000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-061469 | 20240331 | Amortization Of Financing Costs | 177000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Assets Current | 76128000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Cash Paid During The Period For Third Party Interest | 8000.0000 | USD | 1 | 0000950170-25-061469 | |||
0000950170-25-061469 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
0000950170-25-061469 | 20250331 | Common Stock Shares Outstanding | 13068309.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Cost Of Goods And Services Sold | 12367000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Product; | ||
0000950170-25-061469 | 20250331 | Fair Value Adjustment Of Warrants | -4604000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Gain Loss On Sale Of Property Plant Equipment | 3000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20231231 | Goodwill | 7538000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Goodwill | 7139000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Gross Profit | -2108000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -3565000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Increase Decrease In Accounts Payable | 3989000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Increase Decrease In Accounts Payable | 1688000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Increase Decrease In Other Noncurrent Liabilities | -523000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Net Income Loss | -8771000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Operating Income Loss | -12502000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Operating Income Loss | -10560000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Other Assets Noncurrent | 2038000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Other Comprehensive Income Loss Net Of Tax | -181000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000950170-25-061469 | 20240331 | Paid In Kind Interest | 0.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Paid In Kind Interest | 492000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Paid In Kind Non Cash Interest Added To Senior Notes Principal | 492000.0000 | USD | 1 | 0000950170-25-061469 | |||
0000950170-25-061469 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Proceeds From Stock Options Exercised | 3000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Restricted Cash | 1896000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Restricted Cash | 0.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Retained Earnings Accumulated Deficit | -347741000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 18202000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Product; | ||
0000950170-25-061469 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 2601000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Service; | ||
0000950170-25-061469 | 20240331 | Share Based Compensation | 1639000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
0000950170-25-061469 | 20240331 | Stockholders Equity | -474000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
0000950170-25-061469 | 20240331 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | * -Prior year shares and amounts, as applicable, have been revised to reflect the Reverse Stock Split effective November 29, 2024. | |
0000950170-25-061469 | 20250331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
0000950170-25-061469 | 20250331 | Stockholders Equity | -351560000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-061469 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Gross | 50693.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-061469 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 3000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 3000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
0000950170-25-061469 | 20250331 | Treasury Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 14588972.0000 | shares | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Assets | 115030000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Assets Current | 71098000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Common Stock Shares Authorized | 850000000.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Common Stock Shares Issued | 13068309.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Comprehensive Income Net Of Tax | -8952000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Contract With Customer Liability Current | 5306000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Contract With Customer Liability Current | 2237000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Deferred Income Tax Expense Benefit | 225000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 18000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Equity Method Investment Realized Gain Loss On Disposal | 4085000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Equity Method Investments | 954000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Goodwill | 7173000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Income Loss From Equity Method Investments Net Of Dividends Or Distributions | -112000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Increase Decrease In Accounts Receivable | 4437000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Increase Decrease In Inventories | 116000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Increase Decrease In Inventories | -3316000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Liabilities And Stockholders Equity | 84061000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Net Cash Provided By Used In Financing Activities | 0.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Net Income Loss | -3819000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
0000950170-25-061469 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -181000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Paid In Kind Interest | 600000.0000 | USD | 1 | us-gaap/2024 | Longterm Debt Type= Senior Notes; | ||
0000950170-25-061469 | 20250331 | Payments To Acquire Other Investments | 0.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Prepaid Expense And Other Assets Current | 14123000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Provision For Inventory Obsolescence | 177000.0000 | USD | 1 | 0000950170-25-061469 | |||
0000950170-25-061469 | 20240331 | Research And Development Expense | 1439000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 10905000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Product; | ||
0000950170-25-061469 | 20240331 | Selling And Marketing Expense | 2388000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20231231 | Shares Outstanding | 12544533.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-061469 | 20231231 | Shares Outstanding | 1076257.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock1; | ||
0000950170-25-061469 | 20240331 | Shares Outstanding | 12595226.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-061469 | 20250331 | Shares Outstanding | 1076257.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock1; | ||
0000950170-25-061469 | 20240331 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock1; | ||
0000950170-25-061469 | 20250331 | Treasury Stock Common Shares | 1076257.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 12888695.0000 | shares | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Accounts Payable Current | 14636000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Accounts Receivable Net Current | 39709000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Cash And Cash Equivalents At Carrying Value | 11247000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 11247000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
0000950170-25-061469 | 20241231 | Common Stock Shares Authorized | 850000000.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Common Stock Shares Outstanding | 12853823.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Comprehensive Income Net Of Tax | -3791000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Earnings Per Share Diluted | -0.5800 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Income Loss From Equity Method Investments Net Of Dividends Or Distributions | -265000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Income Tax Expense Benefit | -11000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Increase Decrease In Deferred Revenue | 1285000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Increase Decrease In Other Operating Capital Net | 359000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -45000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Liabilities Current | 50898000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Long Term Debt | 10169000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Other Assets Noncurrent | 2341000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Other Liabilities Noncurrent | 2206000.0000 | USD | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Product Warranty Expense | 1045000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 20803000.0000 | USD | 1 | us-gaap/2024 | |||
0000950170-25-061469 | 20241231 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
0000950170-25-061469 | 20250331 | Shares Outstanding | 13068309.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
0000950170-25-061469 | 20231231 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
ddate | The end date for the data value, rounded to the nearest month end. |
qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
uom | The unit of measure for the value. |
segments | Tags used to represent axis and member reporting. |
coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
---|---|---|---|---|---|---|---|---|
Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
Warrant Liability | 0000950170-25-061469 | 1 | 0 | monetary | I | C | Warrant liability | Warrant liability |
Income Loss From Equity Method Investments Net Of Dividends Or Distributions | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Equity Method Investments, Net of Dividends or Distributions | This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities. |
Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
Depreciation And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Restricted Stock Award, Gross | Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. | |
Taxes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Taxes Payable, Current | Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
Paid In Kind Non Cash Interest Added To Senior Notes Principal | 0000950170-25-061469 | 1 | 0 | monetary | D | D | Paid In Kind Non Cash Interest Added To Senior Notes principal | Paid In Kind Non Cash Interest Added To Senior Notes principal |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
Product Warranty Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Product Warranty Expense | The expense charged against earnings for the period pertaining to standard and extended warranties on the entity's goods and services granted to customers. |
Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
Treasury Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Treasury Stock, Value | The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury. |
Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
Cost Of Goods And Services Sold | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Goods and Services Sold | The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. |
Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Gross Profit | us-gaap/2024 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
Income Taxes Paid | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid | Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
Interest Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Operating and Nonoperating | Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. |
Long Term Debt | us-gaap/2024 | 0 | 0 | monetary | I | C | Long-Term Debt | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation. |
Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
Selling And Marketing Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling and Marketing Expense | The aggregate total amount of expenses directly related to the marketing or selling of products or services. |
Cash Paid During The Period For Third Party Interest | 0000950170-25-061469 | 1 | 0 | monetary | D | C | Cash paid during the period for third party interest | Cash paid during the period for third party interest |
Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
Increase Decrease In Other Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid. |
Increase Decrease In Other Operating Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Operating Assets | Amount of increase (decrease) in operating assets classified as other. |
Increase Decrease In Other Operating Capital Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Operating Assets and Liabilities, Net | Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other. |
Payments To Acquire Other Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Other Investments | Amount of cash outflow to acquire investments classified as other. |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
Paid In Kind Interest | us-gaap/2024 | 0 | 0 | monetary | D | D | Paid-in-Kind Interest | Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method. |
Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
Deferred Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Deferred Income Tax Expense (Benefit) | Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. |
Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
Equity Method Investment Realized Gain Loss On Disposal | us-gaap/2024 | 0 | 0 | monetary | D | C | Equity Method Investment, Realized Gain (Loss) on Disposal | Amount of gain (loss) on sale or disposal of an equity method investment. |
Equity Method Investments | us-gaap/2024 | 0 | 0 | monetary | I | D | Equity Method Investments | This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. |
Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
Interest Income Operating | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Income, Operating | Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities. |
Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax | Amount after tax and reclassification adjustments of other comprehensive income (loss). |
Other Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. |
Other Noncash Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Noncash Income (Expense) | Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other. |
Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
Proceeds From Sale Of Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale of Property, Plant, and Equipment | The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. |
Purchase Of Property And Equipment Included In Account Payable | 0000950170-25-061469 | 1 | 0 | monetary | D | C | Purchase Of Property And Equipment Included In Account Payable | Purchase of property and equipment included in account payable. |
Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Goodwill | Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. |
Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
Other Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
Restricted Cash | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash | Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
Provision For Inventory Obsolescence | 0000950170-25-061469 | 1 | 0 | monetary | D | D | Provision For Inventory Obsolescence | Expense charge to establish an inventory obsolesce reserve. |
Warrants Recoverable From Manufacturer | 0000950170-25-061469 | 1 | 0 | monetary | D | C | Warrants Recoverable From Manufacturer | Warrants recoverable from manufacturer. |
Amortization Of Financing Costs | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Debt Issuance Costs | Amount of amortization expense attributable to debt issuance costs. |
Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal | us-gaap/2024 | 0 | 0 | monetary | D | D | Off-Balance-Sheet, Credit Loss, Liability, Credit Loss Expense (Reversal) | Amount of expense (reversal of expense) for expected credit loss for off-balance sheet credit exposure. Excludes off-balance sheet credit exposure accounted for as insurance and instrument accounted for under derivatives and hedging. |
Proceeds From Sale Of Equity Method Investments | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale of Equity Method Investments | The cash inflow associated with the sale of equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence. |
Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
Fair Value Adjustment Of Warrants | us-gaap/2024 | 0 | 0 | monetary | D | D | Fair Value Adjustment of Warrants | Amount of expense (income) related to adjustment to fair value of warrant liability. |
Gain Loss On Sale Of Property Plant Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Disposition of Property Plant Equipment | Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. |
Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
Accounts And Financing Receivable Allowance For Credit Loss | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts and Financing Receivable, Allowance for Credit Loss | Amount of allowance for credit loss of accounts and financing receivables. Includes, but is not limited to, notes and loan receivable. |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
Contract With Customer Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Contract with Customer, Liability, Current | Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. |
Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
Increase Decrease In Deferred Revenue | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Deferred Revenue | Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. |
Increase Decrease In Other Noncurrent Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Other Noncurrent Liabilities | Amount of increase (decrease) in noncurrent operating liabilities classified as other. |
Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
Treasury Stock Common Shares | us-gaap/2024 | 0 | 0 | shares | I | Treasury Stock, Common, Shares | Number of previously issued common shares repurchased by the issuing entity and held in treasury. |
Field Name | Field Description |
---|---|
tag | The unique identifier (name) for a tag in a specific taxonomy release. |
version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
abstract | 1 if the tag is not used to represent a numeric fact. |
datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
---|---|---|---|---|---|---|---|---|---|
0000950170-25-061469 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
0000950170-25-061469 | 2 | 4 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts receivable, net of allowance for credit losses of $1,625 and $1,717 at March 31,2025 and December 31, 2024, respectively | 0 |
0000950170-25-061469 | 2 | 5 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventories | 0 |
0000950170-25-061469 | 2 | 6 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid and other current assets | 0 |
0000950170-25-061469 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
0000950170-25-061469 | 2 | 8 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use assets | 0 |
0000950170-25-061469 | 2 | 9 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
0000950170-25-061469 | 2 | 10 | BS | 0 | H | Goodwill | us-gaap/2024 | Goodwill | 0 |
0000950170-25-061469 | 2 | 11 | BS | 0 | H | Equity Method Investments | us-gaap/2024 | Equity method investment | 0 |
0000950170-25-061469 | 2 | 12 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other assets | 0 |
0000950170-25-061469 | 2 | 13 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
0000950170-25-061469 | 2 | 16 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
0000950170-25-061469 | 2 | 17 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expenses | 0 |
0000950170-25-061469 | 2 | 18 | BS | 0 | H | Taxes Payable Current | us-gaap/2024 | Income taxes payable | 0 |
0000950170-25-061469 | 2 | 19 | BS | 0 | H | Contract With Customer Liability Current | us-gaap/2024 | Deferred revenue | 0 |
0000950170-25-061469 | 2 | 20 | BS | 0 | H | Other Liabilities Current | us-gaap/2024 | Other current liabilities | 0 |
0000950170-25-061469 | 2 | 21 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
0000950170-25-061469 | 2 | 22 | BS | 0 | H | Long Term Debt | us-gaap/2024 | Long-term debt | 0 |
0000950170-25-061469 | 2 | 23 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liability, net of current portion | 0 |
0000950170-25-061469 | 2 | 24 | BS | 0 | H | Warrant Liability | 0000950170-25-061469 | Warrant liability | 0 |
0000950170-25-061469 | 2 | 25 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2024 | Other non-current liabilities | 0 |
0000950170-25-061469 | 2 | 26 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
0000950170-25-061469 | 2 | 27 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 13) | 0 |
0000950170-25-061469 | 2 | 29 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock par value of $0.0001 per share, 10,000,000 shares authorized; none issued as of March 31, 2025 and December 31, 2024 | 0 |
0000950170-25-061469 | 2 | 30 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock par value of $0.0001 per share, 850,000,000 shares authorized; 13,068,309 and 12,853,823 shares issued and outstanding as of March 31, 2025 and December 31, 2024 | 0 |
0000950170-25-061469 | 2 | 31 | BS | 0 | H | Treasury Stock Value | us-gaap/2024 | Treasury stock, at cost; 1,076,257 shares as of March 31, 2025 and December 31, 2024 | 1 |
0000950170-25-061469 | 2 | 32 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
0000950170-25-061469 | 2 | 33 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive loss | 0 |
0000950170-25-061469 | 2 | 34 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
0000950170-25-061469 | 2 | 35 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' equity | 0 |
0000950170-25-061469 | 2 | 36 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
0000950170-25-061469 | 3 | 1 | BS | 1 | H | Accounts And Financing Receivable Allowance For Credit Loss | us-gaap/2024 | Allowance for credit losses | 0 |
0000950170-25-061469 | 3 | 2 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value | 0 |
0000950170-25-061469 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
0000950170-25-061469 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
0000950170-25-061469 | 3 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
0000950170-25-061469 | 3 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
0000950170-25-061469 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
0000950170-25-061469 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
0000950170-25-061469 | 3 | 9 | BS | 1 | H | Treasury Stock Common Shares | us-gaap/2024 | Treasury Stock, Shares | 0 |
0000950170-25-061469 | 4 | 8 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | Total revenue | 0 |
0000950170-25-061469 | 4 | 10 | IS | 0 | H | Cost Of Goods And Services Sold | us-gaap/2024 | Total cost of revenue | 0 |
0000950170-25-061469 | 4 | 11 | IS | 0 | H | Gross Profit | us-gaap/2024 | Gross profit (loss) | 0 |
0000950170-25-061469 | 4 | 13 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
0000950170-25-061469 | 4 | 14 | IS | 0 | H | Selling And Marketing Expense | us-gaap/2024 | Selling and marketing | 0 |
0000950170-25-061469 | 4 | 15 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
0000950170-25-061469 | 4 | 16 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
0000950170-25-061469 | 4 | 17 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
0000950170-25-061469 | 4 | 18 | IS | 0 | H | Interest Expense | us-gaap/2024 | Interest expense | 1 |
0000950170-25-061469 | 4 | 19 | IS | 0 | H | Interest Income Operating | us-gaap/2024 | Interest income | 0 |
0000950170-25-061469 | 4 | 20 | IS | 0 | H | Equity Method Investment Realized Gain Loss On Disposal | us-gaap/2024 | Gain from disposal of investment in unconsolidated subsidiary | 0 |
0000950170-25-061469 | 4 | 21 | IS | 0 | H | Fair Value Adjustment Of Warrants | us-gaap/2024 | Gain from change in fair value of warrant liability | 1 |
0000950170-25-061469 | 4 | 22 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other income, net | 0 |
0000950170-25-061469 | 4 | 23 | IS | 0 | H | Income Loss From Equity Method Investments Net Of Dividends Or Distributions | us-gaap/2024 | Loss from unconsolidated subsidiary | 0 |
0000950170-25-061469 | 4 | 24 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before income taxes | 0 |
0000950170-25-061469 | 4 | 25 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | (Provision for) benefit from income taxes | 1 |
0000950170-25-061469 | 4 | 26 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0000950170-25-061469 | 4 | 28 | IS | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Foreign currency translation adjustments | 0 |
0000950170-25-061469 | 4 | 29 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive loss | 0 |
0000950170-25-061469 | 4 | 31 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic | 0 |
0000950170-25-061469 | 4 | 32 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted | 0 |
0000950170-25-061469 | 4 | 34 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Basic | 0 |
0000950170-25-061469 | 4 | 35 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Diluted | 0 |
0000950170-25-061469 | 5 | 13 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning balance | 0 |
0000950170-25-061469 | 5 | 14 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning balance (in shares) | 0 |
0000950170-25-061469 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2024 | Shares issued during the period for vested restricted stock awards, shares | 0 |
0000950170-25-061469 | 5 | 16 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Issuance of common stock upon exercise of stock options | 0 |
0000950170-25-061469 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Issuance of common stock upon exercise of stock options, shares | 0 |
0000950170-25-061469 | 5 | 19 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation | 0 |
0000950170-25-061469 | 5 | 20 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0000950170-25-061469 | 5 | 21 | EQ | 0 | H | Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Other comprehensive gain (loss) | 0 |
0000950170-25-061469 | 5 | 22 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending balance | 0 |
0000950170-25-061469 | 5 | 23 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending balance (in shares) | 0 |
0000950170-25-061469 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
0000950170-25-061469 | 6 | 4 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
0000950170-25-061469 | 6 | 5 | CF | 0 | H | Depreciation And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
0000950170-25-061469 | 6 | 6 | CF | 0 | H | Fair Value Adjustment Of Warrants | us-gaap/2024 | Gain from change in fair value of warrant liability | 0 |
0000950170-25-061469 | 6 | 7 | CF | 0 | H | Gain Loss On Sale Of Property Plant Equipment | us-gaap/2024 | Gain from sale of property and equipment | 1 |
0000950170-25-061469 | 6 | 8 | CF | 0 | H | Amortization Of Financing Costs | us-gaap/2024 | Amortization of debt discount and issue costs | 0 |
0000950170-25-061469 | 6 | 9 | CF | 0 | H | Paid In Kind Interest | us-gaap/2024 | Paid-in-kind non-cash interest | 0 |
0000950170-25-061469 | 6 | 10 | CF | 0 | H | Provision For Inventory Obsolescence | 0000950170-25-061469 | Provision for obsolete and slow-moving inventory | 0 |
0000950170-25-061469 | 6 | 11 | CF | 0 | H | Income Loss From Equity Method Investments Net Of Dividends Or Distributions | us-gaap/2024 | Loss from unconsolidated subsidiary | 1 |
0000950170-25-061469 | 6 | 12 | CF | 0 | H | Equity Method Investment Realized Gain Loss On Disposal | us-gaap/2024 | Gain from disposal of investment in unconsolidated subsidiary | 1 |
0000950170-25-061469 | 6 | 13 | CF | 0 | H | Product Warranty Expense | us-gaap/2024 | Warranties issued and remediation added | 0 |
0000950170-25-061469 | 6 | 14 | CF | 0 | H | Warrants Recoverable From Manufacturer | 0000950170-25-061469 | Warranty recoverable from manufacturer | 1 |
0000950170-25-061469 | 6 | 15 | CF | 0 | H | Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal | us-gaap/2024 | Credit loss (credits) provisions | 0 |
0000950170-25-061469 | 6 | 16 | CF | 0 | H | Deferred Income Tax Expense Benefit | us-gaap/2024 | Deferred income taxes | 0 |
0000950170-25-061469 | 6 | 17 | CF | 0 | H | Other Noncash Income Expense | us-gaap/2024 | Lease expense and other | 1 |
0000950170-25-061469 | 6 | 19 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivable | 1 |
0000950170-25-061469 | 6 | 20 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | Inventories | 1 |
0000950170-25-061469 | 6 | 21 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid and other current assets | 1 |
0000950170-25-061469 | 6 | 22 | CF | 0 | H | Increase Decrease In Other Operating Assets | us-gaap/2024 | Other assets | 1 |
0000950170-25-061469 | 6 | 23 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
0000950170-25-061469 | 6 | 24 | CF | 0 | H | Increase Decrease In Other Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accruals and other current liabilities | 0 |
0000950170-25-061469 | 6 | 25 | CF | 0 | H | Increase Decrease In Deferred Revenue | us-gaap/2024 | Deferred revenue | 0 |
0000950170-25-061469 | 6 | 26 | CF | 0 | H | Increase Decrease In Other Noncurrent Liabilities | us-gaap/2024 | Other non-current liabilities | 0 |
0000950170-25-061469 | 6 | 27 | CF | 0 | H | Increase Decrease In Other Operating Capital Net | us-gaap/2024 | Lease payments and other, net | 1 |
0000950170-25-061469 | 6 | 28 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operations | 0 |
0000950170-25-061469 | 6 | 30 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property and equipment | 1 |
0000950170-25-061469 | 6 | 31 | CF | 0 | H | Proceeds From Sale Of Property Plant And Equipment | us-gaap/2024 | Proceeds from sale of property and equipment | 0 |
0000950170-25-061469 | 6 | 32 | CF | 0 | H | Payments To Acquire Other Investments | us-gaap/2024 | Equity method investment in Alpha Steel | 1 |
0000950170-25-061469 | 6 | 33 | CF | 0 | H | Proceeds From Sale Of Equity Method Investments | us-gaap/2024 | Proceeds from disposal of investment in unconsolidated subsidiary | 0 |
0000950170-25-061469 | 6 | 34 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by (used in) investing activities | 0 |
0000950170-25-061469 | 6 | 36 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Proceeds from stock option exercises | 0 |
0000950170-25-061469 | 6 | 37 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
0000950170-25-061469 | 6 | 38 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Effect of exchange rate changes on cash, cash equivalents and restricted cash | 0 |
0000950170-25-061469 | 6 | 39 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Decrease in cash, cash equivalents and restricted cash | 0 |
0000950170-25-061469 | 6 | 40 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at beginning of period | 0 |
0000950170-25-061469 | 6 | 41 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at end of period | 0 |
0000950170-25-061469 | 6 | 43 | CF | 0 | H | Purchase Of Property And Equipment Included In Account Payable | 0000950170-25-061469 | Purchases of property and equipment included in ending accounts payable and accruals | 0 |
0000950170-25-061469 | 6 | 44 | CF | 0 | H | Paid In Kind Non Cash Interest Added To Senior Notes Principal | 0000950170-25-061469 | Paid-in-kind non-cash interest added to Senior Notes principal | 0 |
0000950170-25-061469 | 6 | 45 | CF | 0 | H | Cash Paid During The Period For Third Party Interest | 0000950170-25-061469 | Cash paid during the period for interest | 0 |
0000950170-25-061469 | 6 | 46 | CF | 0 | H | Income Taxes Paid | us-gaap/2024 | Cash paid during the period for taxes, net of refunds | 0 |
0000950170-25-061469 | 6 | 48 | CF | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
0000950170-25-061469 | 6 | 49 | CF | 0 | H | Restricted Cash | us-gaap/2024 | Restricted cash | 0 |
0000950170-25-061469 | 6 | 50 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Total cash, cash equivalents and restricted cash | 0 |
Field Name | Field Description |
---|---|
adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
stmt | The financial statement location to which the value of the “report” field pertains. |
inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
tag | The tag chosen by the filer for this line item. |
version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
plabel | The text presented on the line item, also known as a “preferred” label. |
negating | Flag to indicate whether the plabel is negating. |